Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry I Freedman

Showing results (21-30 of 546) with videos related to

Pageof 55
Sort By:
Journal of the American Society of Nephrology : JASN|March 11, 2018
Evaluation of Potential Living Kidney Donors in the <i>APOL1</i> EraBarry I Freedman, Bruce A Julian
Kidney360|April 4, 2022
Apolipoprotein L1 Gene Testing Comes of AgeBarry I Freedman, Chris P Larsen
Archives of Internal Medicine|June 15, 2007
Chronic kidney disease: cause and consequence of cardiovascular diseaseBarry I Freedman, Thomas D Dubose
Current Diabetes Reports|May 11, 2012
Insights into the genetic architecture of diabetic nephropathyNicholette D Palmer, Barry I Freedman
Kidney International|June 22, 2021
APOL1-associated kidney disease in northern Nigerians with treated HIV infectionOpeyemi A Olabisi, Barry I Freedman
Kidney International|June 22, 2021
APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro)Barry I Freedman, Emilio D Poggio
Diabetes|July 25, 2012
The challenging search for diabetic nephropathy genesDonald W Bowden, Barry I Freedman
Expert Review of Cardiovascular Therapy|April 2, 2011
Effects of race on albuminuria and risk of cardiovascular and kidney diseaseVardaman M Buckalew, Barry I Freedman
Nature Reviews. Nephrology|October 20, 2011
Risk factors: Race, renal disease and albuminuriaBarry I Freedman, Donald W Bowden
Advances in Chronic Kidney Disease|April 27, 2019
The Impact of APOL1 on Chronic Kidney Disease and HypertensionTodd W Robinson, Barry I Freedman
Pageof 55

Showing results (21-30 of 546) with videos related to

Sort By:
Pageof 55
Journal of the American Society of Nephrology : JASN|March 11, 2018
Evaluation of Potential Living Kidney Donors in the <i>APOL1</i> EraBarry I Freedman, Bruce A Julian
Kidney360|April 4, 2022
Apolipoprotein L1 Gene Testing Comes of AgeBarry I Freedman, Chris P Larsen
Archives of Internal Medicine|June 15, 2007
Chronic kidney disease: cause and consequence of cardiovascular diseaseBarry I Freedman, Thomas D Dubose
Current Diabetes Reports|May 11, 2012
Insights into the genetic architecture of diabetic nephropathyNicholette D Palmer, Barry I Freedman
Kidney International|June 22, 2021
APOL1-associated kidney disease in northern Nigerians with treated HIV infectionOpeyemi A Olabisi, Barry I Freedman
Kidney International|June 22, 2021
APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro)Barry I Freedman, Emilio D Poggio
Diabetes|July 25, 2012
The challenging search for diabetic nephropathy genesDonald W Bowden, Barry I Freedman
Expert Review of Cardiovascular Therapy|April 2, 2011
Effects of race on albuminuria and risk of cardiovascular and kidney diseaseVardaman M Buckalew, Barry I Freedman
Nature Reviews. Nephrology|October 20, 2011
Risk factors: Race, renal disease and albuminuriaBarry I Freedman, Donald W Bowden
Advances in Chronic Kidney Disease|April 27, 2019
The Impact of APOL1 on Chronic Kidney Disease and HypertensionTodd W Robinson, Barry I Freedman
Pageof 55